Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TLT vs MRNA✓SelectedUSD · MRNATLT vs MRNA performance historyLatest closeAs of+0.84%11/18
Stock and ETF performance explorer

TLT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-14.3%
MRNA return
+794.5%
Excess return
-808.8%
Maximum drawdown
-48.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.8%-4.8%+5.7%+0.9%
7D-0.9%-20.9%+20.0%-0.6%
30D+1.4%-13.3%+14.6%+1.5%
3M-0.6%+212.6%-213.1%-3.3%
6M-1.7%+309.0%-310.7%-4.9%
YTD-4.4%+567.3%-571.7%-8.3%
1Y-5.7%+689.7%-695.4%-9.9%
3Y+1.3%+157.4%-156.1%-1.9%
5Y-34.4%-21.7%-12.7%-35.9%
All-14.3%+794.5%-808.8%-16.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling